New York, December 8, 2017 – SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced …
Dec 14, 2017
/
News
Nov 30, 2017
/
Wavelength Pharmaceuticals Names Iftach Seri as Chief Executive Officer and Tami Cohen as Chief Financial Officer
Tel Aviv, Israel, November 28, 2017 – Wavelength Pharmaceuticals Ltd. (“Wavelength” or the “Company”), a former subsidiary of Perrigo Company plc that was …
Nov 21, 2017
/
SK Capital Closes Acquisition of Perrigo’s API Business and Changes Name to Wavelength Pharmaceuticals
New York, NY and Tel Aviv, Israel, November 21, 2017 – SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals …
Oct 03, 2017
/
SK Capital Expands Team with Two New Professionals
NEW YORK, October 3, 2017 – SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceutical …
Aug 17, 2017
/
SK CAPITAL CONTINUES TO INVEST IN ARCHROMA
New Investment Aimed to Support the Company’s Growth and Potential Industry Consolidation NEW YORK and BASEL, SWITZERLAND, August 17, 2017 – SK Capital …
Aug 11, 2017
/
SK Capital Announces Agreement to Acquire Perrigo Company plc’s Active Pharmaceutical Ingredients Business
New York, August 10, 2017 – SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, announced that it …